PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis. Issue 1 (20th November 2021)

• Record Type: Journal Article
• Authors: Yang, Weili; Guo, Xiangyu; Tu, Zhuchi; Chen, Xiusheng; Han, Rui; Liu, Yanting; Yan, Sen; Wang, Qi; Wang, Zhifu; Zhao, Xianxian; Zhang, Yunpeng; Xiong, Xin; Yang, Huiming; Yin, Peng; Wan, Huida; Chen, Xingxing; Guo, Jifeng; Yan, Xiao-Xin; Liao, Lujian; Li, Shihua; Li, Xiao-Jiang
• Is Part Of: Protein & cell. Volume 13:Issue 1(2022)
• Page Start: 26
• Page End: 46
• Publication Date: 2021-11-20
• Subjects: Parkinson's disease -- neurogenesis -- neurodegeneration -- mitochondria -- non-human primates; Proteins -- Periodicals; Cells -- Periodicals; Cytology -- Periodicals; 572.6
• DOI: 10.1007/s13238-021-00888-x
• Languages: English
• ISSNs: 1674-800X

Abstract

ABSTRACT: In vitro studies have established the prevalent theory that the mitochondrial kinase PINK1 protects neurodegeneration by removing damaged mitochondria in Parkinson's disease (PD). However, difficulty in detecting endogenous PINK1 protein in rodent brains and cell lines has prevented the rigorous investigation of the in vivo role of PINK1. Here we report that PINK1 kinase form is selectively expressed in the human and monkey brains. CRISPR/Cas9-mediated deficiency of PINK1 causes similar neurodegeneration in the brains of fetal and adult monkeys as well as cultured monkey neurons without affecting mitochondrial protein expression and morphology. Importantly, PINK1 mutations in the primate brain and human cells reduce protein phosphorylation that is important for neuronal function and survival. Our findings suggest that PINK1 kinase activity rather than its mitochondrial function is essential for the neuronal survival in the primate brains and that its kinase dysfunction could be involved in the pathogenesis of PD.